Pathogen-Specific Clinical Trials: A New Paradigm in Clinical Trials for Multidrug-Resistant Organisms Sarah C. J. JorgensenMichael J. Rybak Editorial Open access 03 October 2018 Pages: 401 - 405
HIV, HCV and HBV: A Review of Parallels and Differences Maria C. LeoniAndrew UstianowskiJoop E. Arends Review Open access 04 September 2018 Pages: 407 - 419
Systematic Review of Invasive Meningococcal Disease: Sequelae and Quality of Life Impact on Patients and Their Caregivers Kerstin J. OlbrichDirk MüllerFlorian Koerber Review Open access 28 September 2018 Pages: 421 - 438
Effect and Safety of Meropenem–Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial Richard G. WunderinkEvangelos J. Giamarellos-BourboulisKeith S. Kaye Original Research Open access 01 October 2018 Pages: 439 - 455
A Markov Model to Estimate Mortality Due to HIV/AIDS Using Viral Load Levels-Based States and CD4 Cell Counts: A Principal Component Analysis Approach Claris ShokoDelson ChikobvuPascal O. Bessong Original Research Open access 02 November 2018 Pages: 457 - 471
Pan-Genotypic Hepatitis C Treatment with Glecaprevir and Pibrentasvir for 8 Weeks Resulted in Improved Cardiovascular and Metabolic Outcomes and Stable Renal Function: A Post-Hoc Analysis of Phase 3 Clinical Trials Tram T. TranDarshan MehtaYuri Sanchez Gonzalez Original Research Open access 27 October 2018 Pages: 473 - 484
Consider Syphilis in Case of Lymphopenia in HIV-Infected Men Who Have Sex with Men (MSM): A Single-center, Retrospective Study Georgios SogkasDiana ErnstMatthias Stoll Original Research Open access 30 October 2018 Pages: 485 - 494
Development of a Risk-Scoring Tool to Determine Appropriate Level of Care in Acute Bacterial Skin and Skin Structure Infections in an Acute Healthcare Setting Kimberly C. ClaeysEvan J. ZasowskiMichael J. Rybak Original Research Open access 22 September 2018 Pages: 495 - 507
Efficacy and Safety of Tedizolid and Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Injection Drug Users: Analysis of Two Clinical Trials Gregory J. MoranCarisa De AndaPhilippe Prokocimer Original Research Open access 21 September 2018 Pages: 509 - 522
Prevalence of Clostridium Difficile-Associated Diarrhoea in Hospitalised Patients (Results of a Russian Prospective Multicentre Study) Natalia V. DmitrievaGalina A. KlyasovaStanislav V. Kazakov Original Research Open access 10 September 2018 Pages: 523 - 534
Comment on: ‘Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada’, Wilson et al., 22 June 2018 Ashleigh McGirrShehzad M. IqbalLijoy Varghese Letter Open access 08 November 2018 Pages: 535 - 538
Response to McGirr et al.'s Comment on “Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada” Michele R. WilsonMatt WassermanRaymond Farkouh Letter Open access 08 November 2018 Pages: 539 - 543